US Edition
Researcher of Santo Tomás Temuco Advances in Development of New Biopharmaceutical Against Leukemia - Diario clave9.cl
Summary by clave9.cl
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
In laboratories of the Universidad Santo Tomás Temuco, research is being developed that could change the paradigm of treatment for acute lymphoblastic leukemia, an oncological disease that mainly affects children. The initiative, led by Dr. Lisandra Herrera, academic and researcher with extensive experience in biotechnology and pharmacology, represents a concrete advance from regions in the generation of scientific knowledge with global impact. …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
